Literature DB >> 29231485

[HE Xingwei's exploration and experience in the pathogenesis and treatment of motor impairment of the trunk after stroke].

Peng Zhang1, Songfeng Hu2, Fan He3, Jinying Fang1, Qiang Wang1, Xingwei He4.   

Abstract

In the paper, it is introduced professor HE Xingwei's recognition on the pathogenesis and professor HE's experience in the treatment of the motor impairment of the trunk after stroke. Professor He believes that the motor impairment of the trunk after stroke is the essential factor affecting the rehabilitation in stroke. The motor impairment of the trunk after stroke results from brain marrow damage and spiritual impairment. Hence, regaining the consciousness and promoting the circulation of the governor vessel are the basic principles of the treatment, named regulating the mind and controlling qi, benefiting qi and warming yang, tonifying the kidney and filling up the essence, and promoting the circulation of the governor vessel. Those four therapeutic methods are equally important. Acupuncture, moxibusiton and herbal medicine are applied in combination in the treatment. Additionally, the psychotherapy and rehabilitation are the accessory therapies.

Entities:  

Keywords:  brain marrow and spiritual mechanism; experience of famous doctor; motor impairment of trunk; stroke; the governor vessel; yang qi

Mesh:

Year:  2017        PMID: 29231485     DOI: 10.13703/j.0255-2930.2017.02.024

Source DB:  PubMed          Journal:  Zhongguo Zhen Jiu        ISSN: 0255-2930


  2 in total

Review 1.  Research progress on the protective effects of aucubin in neurological diseases.

Authors:  Ping Yang; Qiaoyue Zhang; Hengyan Shen; Xinyu Bai; Ping Liu; Tao Zhang
Journal:  Pharm Biol       Date:  2022-12       Impact factor: 3.889

2.  Rehabilitation Treatment of Motor Dysfunction Patients Based on Deep Learning Brain-Computer Interface Technology.

Authors:  Huihai Wang; Qinglun Su; Zhenzhuang Yan; Fei Lu; Qin Zhao; Zhen Liu; Fang Zhou
Journal:  Front Neurosci       Date:  2020-10-22       Impact factor: 4.677

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.